Natural Product: NPC138710

Natural Product IDNPC138710
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
FTAGQROYQYQRHF-CBVHGRPESA-N
IUPAC Name n.a.
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID 24875302
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0003909] Fatty Acyls
        • [CHEMONTID:0000513] Eicosanoids
          • [CHEMONTID:0000214] Hydroxyeicosapentaenoic acids

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey FTAGQROYQYQRHF-CBVHGRPESA-N
Standard InCHI InChI=1S/C20H30O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-16-19(21)17-15-18-20(22)23/h3-4,6-7,9-10,12-14,16,19,21H,2,5,8,11,15,17-18H2,1H3,(H,22,23)/b4-3-,7-6-,10-9-,13-12-,16-14+/t19-/m0/s1
SMILES CC/C=CC/C=CC/C=CC/C=CC=C[C@@H](CCCC(=O)O)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   318.22 Volume:   365.028
?
Van der Waals volume.
Dense:   0.872 LogP:   4.615
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   2.993
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -3.479
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   13.0 Rigid Bonds:   6.0
TPSA:   57.53
?
Topological Polar Surface Area.
H-Bond Acceptor:   3.0
H-Bond Donor:   2.0 Rings:   0.0
Heavy Atoms:   3.0

MedChem Properties

QED Drug-Likeness Score:   0.372 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   3.605 Fsp3:   0.45
MCE-18:   2.0
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Accepted GSK Rule:   Accepted
Golden Triangle Rule:   Rejected BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.088 Fluc inhibitor:   0.009
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.006
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.02
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.95 Promiscuous compounds:   0.276

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.02 MDCK Permeability:   -4.767
Pgp-inhibitor:   0.003 Pgp-substrate:   0.001
PAMPA:   0.507
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.056
20% Bioavailability (F20%):   0.572 30% Bioavailability (F30%):   0.836
50% Bioavailability (F50%):   0.63

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.001 MRP1:   0.967
Plasma Protein Binding (PPB):   97.661% Volume Distribution (VD):   -0.384
Fu: 2.988%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.035
OATP1B3 inhibitor:   0.705 BCRP inhibitor:   0.02
BSEP inhibitor:   0.973

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   1.0 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.996 CYP2D6-substrate:   0.003
CYP3A4-inhibitor:   0.0 CYP3A4-substrate:   0.831
CYP2B6-substrate:   0.237 CYP2C8-inhibitor:   0.999
HLM stability:   0.0
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  8.034 Half-life (T1/2):  0.307

ADMET: Toxicity

hERG Blockers:  0.284 hERG Blockers (10um):  0.314
Human Hepatotoxicity (H-HT):  0.002 Drug-induced Liver Injury (DILI):  0.0
AMES Toxicity:  0.92 Rat Oral Acute Toxicity:  0.084
Maximum Recommended Daily Dose:  0.001 Skin Sensitization:  1.0
Carcinogencity:  0.002 Eye Corrosion:  1.0
Eye Irritation:  1.0 Respiratory Toxicity:  0.999
Drug-induced Neurotoxicity:  0.032 Ototoxicity:  0.069
Hematotoxicity:  0.0 Drug-induced Nephrotoxicity:  0.177
Genotoxicity:  0.0 RPMI-8226 Immunitoxicity:  0.008
A549 Cytotoxicity:  0.019 Hek293 Cytotoxicity:  0.0
BCF:   0.997
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.747
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   5.137
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.132
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO22821 Chamaecyparis obtusa Species Cupressaceae Eukaryota n.a. heartwood n.a. DOI[10.1007/s10086-012-1280-8]
NPO22821 Chamaecyparis obtusa Species Cupressaceae Eukaryota n.a. n.a. n.a. PMID[16540181]
NPO4208 Gardneria ovata Species Loganiaceae Eukaryota n.a. n.a. n.a. PMID[21425787]
NPO4208 Gardneria ovata Species Loganiaceae Eukaryota n.a. aerial part n.a. PMID[21425787]
NPO22821 Chamaecyparis obtusa Species Cupressaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO22821 Chamaecyparis obtusa Species Cupressaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO22821 Chamaecyparis obtusa Species Cupressaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO4208 Gardneria ovata Species Loganiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO22821 Chamaecyparis obtusa Species Cupressaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC138710 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.7857 Intermediate Similarity NPC323045
0.7857 Intermediate Similarity NPC317881
0.7436 Intermediate Similarity NPC322002
0.7209 Intermediate Similarity NPC327112
0.6905 Remote Similarity NPC324475
0.6042 Remote Similarity NPC605544
0.6042 Remote Similarity NPC607260
0.6 Remote Similarity NPC255863
0.6 Remote Similarity NPC136164
0.6 Remote Similarity NPC245947
0.5957 Remote Similarity NPC49863
0.587 Remote Similarity NPC323477
0.5532 Remote Similarity NPC325627
0.54 Remote Similarity NPC328653
0.5385 Remote Similarity NPC117572
0.5366 Remote Similarity NPC70387
0.5306 Remote Similarity NPC26500
0.5238 Remote Similarity NPC52955
0.5238 Remote Similarity NPC88966
0.5238 Remote Similarity NPC25417
0.5238 Remote Similarity NPC1813
0.5122 Remote Similarity NPC149821

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC138710 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7209 Intermediate Similarity NPD4246 Phase 2
0.5957 Remote Similarity NPD4247 Clinical (unspecified phase)
0.5385 Remote Similarity NPD4222 Phase 3
0.5238 Remote Similarity NPD3172 Approved

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data